logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Metin Özkan

erciyes university
H指数:20
被引数:1,327
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib

体重指数与接受舒尼替尼或帕唑帕尼治疗的转移性肾细胞癌患者治疗毒性的关联

Cancers
IF4.4
2026-08-280
OA
Ahmet Kürşad Dişli; Ayşe Nuransoy Cengiz; Muhammet Cengiz; İrfan Buğday; Sinan Yıldırım; Rıdvan Gönül; Oktay Bozkurt; Mevlüde İnanç; Metin Özkan
The role of the prognostic nutritional index at baseline and follow-up in patients with metastatic prostate cancer

基线和随访时预后营养指数在转移性前列腺癌患者中的作用

Discover Oncology
IF2.9
2026-08-030
OA
Muhammet Cengiz; Ayşe Nuransoy Cengiz; Oktay Bozkurt; Gozde Erturk Zararsiz; Ahmet Kursat Disli; Ridvan Gonul; Kamuran Yuceer; Irfan Bugday; Aleyna Erakcaoğlu; Emel Mutlu Ozkan; Mevlude Inanc; Metin Ozkan
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients

比较固定剂量与体重基础剂量纳武利尤单抗治疗非小细胞肺癌患者的疗效

Scientific Reports
IF3.9
2026-05-080
OAAI
Muhammet Cengiz; Oktay Bozkurt; Ayse Nuransoy Cengiz; Deniz Can Guven; Elif Sahin; Emel Mutlu Ozkan; Mustafa Ersoy; Ezgi Turkoğlu; Sedat Yildirim; Erdem Kolemen; Beyza Unlu; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Latif Karahan; Mustafa Erman; Ismail Oguz Kara; Meltem Baykara; Pervin Can Sanci; Anıl Karakayali; Umut Kefeli; Devrim Cabuk; Saadettin Kilickap; Teoman Sakalar; Nargiz Majidova; Berrak Mermit Ercek; Muslih Urun; Gözde Agdas; Duygu Bayir; Cengiz Akosman; Erkam Kocaaslan; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; Mevlude Inanc; Metin Ozkan
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab

基线维生素D状态及接受纳武利尤单抗治疗的晚期非小细胞肺癌患者的临床结局

Scientific Reports
IF3.9
2026-04-140
OAAI
Gözde Ağdaş; Duygu Bayir; Elif Şahin; Muhammet Cengiz; Deniz Can Güven; Mehmet Salim Demir; Ertuğrul Bayram; Duygu Özaşkın; Meltem Baykara; Oktay Bozkurt; Mevlüde İnanç; Metin Özkan; Ayşe Nuransoy Cengiz; Mustafa Erman; Umut Kefeli; Emel Mutlu Özkan; Erkam Kocaaslan; Devrim Çabuk; Saadettin Kiliçkap; Pervin Can Sanci; Muslih Urun; Teoman Sakalar; Cengiz Akosman; Erdem Kolemen; Ezgi Turkoğlu; Anıl Karakayali; Mustafa Ersoy; Sedat Yildirim; Latif Karahan; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Berrak Mermit Ercek; Nargiz Majidova; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; İbrahim Karadağ
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

接受免疫疗法治疗的晚期肺癌患者中，早期肺部免疫预后指数变化的预后意义

Discover Oncology
IF2.9
2026-02-210
OAAI
Muhammet Cengiz; Oktay Bozkurt; Ayşe Nuransoy Cengiz; Mevlude Inanc; Metin Ozkan; Emel Mutlu Ozkan; Deniz Can Guven; Mustafa Erman; Latif Karahan; Elif Sahin; Anıl Karakayali; Pervin Can Sanci; Umut Kefeli; Devrim Cabuk; Erdem Kolemen; Mehmet Mutlu Kidi; Sedat Biter; Tolga Koseci; Muslih Urun; Berrak Mermit Ercek; Duygu Bayir; Gözde Agdas; Teoman Sakalar; Nargiz Majidova; Sedat Yildiz; Hacer Demir; Cengiz Akosman; Mustafa Ersoy; Saadettin Kilickap; Erkam Kocaaslan; Ezgi Turkoğlu; Sedat Yildirim; Hayati Arvas; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas
Dynamic Immune–Nutritional Indices as Powerful Predictors of Pathological Complete Response in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Journal of Clinical Medicine
IF2.9
2026-01-260
OAAI
Emel Mutlu Ozkan; Ibrahim Karadag; Mevlude Inanc; Metin Ozkan
Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non-Small-Cell Lung Cancer
CLINICAL LUNG CANCER
IF3.3
2023-05-013
PRE
Duran, Ayse Ocak; Inanc, Mevlude; Bozkurt, Oktay; Ozaslan, Ersin; Ozkan, Metin
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey
FUTURE ONCOLOGY
IF2.6
2022-08-303
OA
Ozet, Ahmet; Dane, Faysal; Aykan, Nuri Faruk; Yalcin, Suayib; Evrensel, Turkkan; Ozkan, Metin; Karabulut, Bulent; Ormeci, Merve Nur; Atasev, Ozan; Vidot, Loick; Cicin, Irfan
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer
FUTURE ONCOLOGY
IF2.6
2021-07-292
PRE
Topcu, Atakan; Atci, Muhammed Mustafa; Secmeler, Saban; Besiroglu, Mehmet; Ayhan, Murat; Ozkan, Metin; Bozkurt, Oktay; Urakci, Zuhat; Ay, Seval; Geredeli, Caglayan; Yasin, Ayse Irem; Turk, Haci Mehmet
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine plus nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study
BMC CANCER
IF3.4
2020-03-3012
OAAI
Yalcin, Suayib; Dane, Faysal; Oksuzoglu, Berna; Ozdemir, Nuriye Yildirim; Isikdogan, Abdurrahman; Ozkan, Metin; Demirag, Guzin Gonullu; Coskun, Hasan Senol; Karabulut, Bulent; Evrensel, Turkkan; Ustaoglu, Mehmet Ali; Ozdemir, Feyyaz; Turna, Hande; Yavuzsen, Tugba; Aykan, Faruk; Sevinc, Alper; Akbulut, Hakan; Yuce, Deniz; Hayran, Mutlu; Kilickap, Saadettin
An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
ANNALS OF ONCOLOGY
IF65.4
2015-06-010
OAAI
Dane, F.; Ozgurdal, K.; Yalcin, S.; Benekli, M.; Aykan, N. F.; Yucel, I.; Ozkan, M.; Evrensel, T.; Sevinc, A.; Coskun, H. S.; Sanli, U. S.; Kara, I. O.
Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)
BREAST CANCER
IF2.9
2013-12-122
PREAI
Icli, Fikri; Altundag, Kadri; Akbulut, Hakan; Paydas, Semra; Basaran, Gul; Saip, Pinar; Dogu, Gamze G.; Erlap, Yesim; Uslu, Ruchan; Sevinc, Alper; Onur, Handan; Mandel, Nil M.; Sezgin, Canfeza; Altinbas, Mustafa; Guler, Nilufer; Isikdogan, Abdurrahman; Gokmen, Erhan; Uygun, Kazim; Ustuner, Zeki; Yaren, Arzu; Demirkan, Binnaz; Coskun, Ugur; Ata, Alper; Ozkan, Metin; Arican, Ali
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial
BREAST
IF7.9
2013-10-017
OAAI
Saip, P.; Eralp, Y.; Sen, F.; Karaca, H.; Ozkan, M.; Cetin, B.; Benekli, M.; Kucukoner, M.; Isikdogan, A.; Un, O.; Basaran, G.; Onur, H.

研究方向

暂未获取到该数据
O
Oktay Bozkurt
H 指数:15论文数:92被引数:593
M
Mevlüde İnanç
H 指数:13论文数:79被引数:666
E
Emel Mutlu
H 指数:7论文数:28被引数:131
A
Ayşe Nuransoy Cengi̇z
H 指数:3论文数:21被引数:81
S
Saadettin Kılıçkap
H 指数:31论文数:465被引数:4,922
U
Umut Kefeli
H 指数:17论文数:95被引数:1,083
M
Mehmet Mutlu Kıdı
H 指数:3论文数:39被引数:32
A
Abdurrahman Işıkdoğan
H 指数:25论文数:278被引数:2,029
M
Mustafa Erman
H 指数:27论文数:243被引数:8,710
T
Teoman Şakalar
H 指数:9论文数:125被引数:298